[HTML][HTML] Acute myeloid leukemia: current progress and future directions
H Kantarjian, T Kadia, C DiNardo, N Daver… - Blood cancer …, 2021 - nature.com
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML)
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
[PDF][PDF] Acute myeloid leukemia: current progress and future directions
H Kantarjian, T Kadia, C DiNardo, N Daver… - 2021 - thd.org.tr
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML)
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
Acute myeloid leukemia: current progress and future directions
H Kantarjian, T Kadia, C DiNardo… - Blood cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML)
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
[引用][C] Acute myeloid leukemia: current progress and future directions
H Kantarjian, T Kadia, C DiNardo, N Daver… - Blood Cancer …, 2021 - elibrary.ru
Acute myeloid leukemia: current progress and future directions
K Hagop, K Tapan, C DiNardo, D Naval… - Blood Cancer …, 2021 - search.proquest.com
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML)
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
Acute myeloid leukemia: current progress and future directions.
H Kantarjian, T Kadia, C DiNardo… - Blood Cancer …, 2021 - search.ebscohost.com
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML)
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
Acute myeloid leukemia: current progress and future directions.
H Kantarjian, T Kadia, C DiNardo, N Daver… - Blood Cancer …, 2021 - europepmc.org
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML)
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
Acute myeloid leukemia: current progress and future directions
H Kantarjian, T Kadia, C DiNardo… - Blood cancer …, 2021 - mdanderson.elsevierpure.com
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML)
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
[HTML][HTML] Acute myeloid leukemia: current progress and future directions
H Kantarjian, T Kadia, C DiNardo, N Daver… - Blood Cancer …, 2021 - ncbi.nlm.nih.gov
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML)
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
Acute myeloid leukemia: current progress and future directions
H Kantarjian, T Kadia, C DiNardo… - Blood cancer …, 2021 - einstein.elsevierpure.com
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML)
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …
is occurring rapidly. Since 2017, nine agents have been approved for various indications in …